| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |